| Title : Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years - Farlow_2005_BMC.Geriatr_5_3 |
| Author(s) : Farlow MR , Lilly ML |
| Ref : BMC Geriatr , 5 :3 , 2005 |
| Abstract : Farlow_2005_BMC.Geriatr_5_3 |
| ESTHER : Farlow_2005_BMC.Geriatr_5_3 |
| PubMedSearch : Farlow_2005_BMC.Geriatr_5_3 |
| PubMedID: 15659242 |
Farlow MR, Lilly ML (2005)
Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years
BMC Geriatr
5 :3
Farlow MR, Lilly ML (2005)
BMC Geriatr
5 :3